Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Radiation Fibrosis Syndrome 1Precancerous Conditions 1Pancreatic Neoplasms 1Lung Neoplasms 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Early Intervention, Educational 30Educational Status 29Blood Specimen Collection 28Standard of Care 27Methods 25Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Practice Guidelines as Topic 18Surveys and Questionnaires 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Interviews as Topic 11Biopsy 11Specimen Handling 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Breathing Exercises 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Losartan × Clear all
NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡